Loading...
IP logo

Inter Pharma Public Company LimitedSET:IP Stock Report

Market Cap ฿2.4b
Share Price
฿4.00
Future Cash Flow Value
n/a
1Y12.4%
7D-6.1%
Portfolio Value
View

Inter Pharma Public Company Limited

SET:IP Stock Report

Market Cap: ฿2.4b

Inter Pharma (IP) Stock Overview

Manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. More details

IP fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

IP Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Inter Pharma Public Company Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Inter Pharma
Historical stock prices
Current Share Price฿4.00
52 Week High฿4.70
52 Week Low฿2.96
Beta0.47
1 Month Change-1.96%
3 Month Change-12.28%
1 Year Change12.36%
3 Year Change-49.61%
5 Year Change-70.05%
Change since IPO1.11%

Recent News & Updates

Recent updates

Shareholder Returns

IPTH Personal ProductsTH Market
7D-6.1%-5.2%1.2%
1Y12.4%-12.1%24.0%

Return vs Industry: IP exceeded the TH Personal Products industry which returned -13.1% over the past year.

Return vs Market: IP underperformed the TH Market which returned 20.6% over the past year.

Price Volatility

Is IP's price volatile compared to industry and market?
IP volatility
IP Average Weekly Movement4.1%
Personal Products Industry Average Movement4.1%
Market Average Movement4.9%
10% most volatile stocks in TH Market9.9%
10% least volatile stocks in TH Market2.4%

Stable Share Price: IP has not had significant price volatility in the past 3 months compared to the TH market.

Volatility Over Time: IP's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006n/aTrinnawat Thanitnithiphanwww.interpharma.co.th

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equipment and medicines, etc. It also provides pet healthcare and livestock products, such as medical supplies, nutrition therapy, vaccine, supplementary food, probiotic and prebiotic products, animal health food products, animal food, general formula animal food, nutraceuticals and medicine companion products, ear and teeth cleaners, pee pads, shampoos, and medical equipment related to pet and livestock care product, etc. In addition, the company provides care and treatment for patients with general and specialized diseases, such as cardiovascular disease, bone and joint disease, neuropathy, medical diseases, surgical diseases, kidney disease, obstetrics and gynecology, ear, eye, nose, throat diseases, blood diseases, pediatric clinics, etc. It serves retail customers through distributors.

Inter Pharma Public Company Limited Fundamentals Summary

How do Inter Pharma's earnings and revenue compare to its market cap?
IP fundamental statistics
Market cap฿2.43b
Earnings (TTM)฿122.38m
Revenue (TTM)฿2.21b
19.8x
P/E Ratio
1.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IP income statement (TTM)
Revenue฿2.21b
Cost of Revenue฿1.29b
Gross Profit฿920.76m
Other Expenses฿798.38m
Earnings฿122.38m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.20
Gross Margin41.59%
Net Profit Margin5.53%
Debt/Equity Ratio13.3%

How did IP perform over the long term?

See historical performance and comparison

Dividends

1.8%
Current Dividend Yield
36%
Payout Ratio

Does IP pay a reliable dividends?

See IP dividend history and benchmarks
When do you need to buy IP by to receive an upcoming dividend?
Inter Pharma dividend dates
Ex Dividend DateMay 06 2026
Dividend Pay DateMay 25 2026
Days until Ex dividend41 days
Days until Dividend pay date60 days

Does IP pay a reliable dividends?

See IP dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/25 23:16
End of Day Share Price 2026/03/25 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Inter Pharma Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.